For Lab R&D Uses Only

Purity:               >98% (HPLC)

Product Description:

Novel EphA4 receptor antagonistic peptide, binding to the ligand-binding domain of EphA4, exhibiting higher binding to LNCaP cells, effectively alleviating Aβ-induced synaptic dysfunction and synaptic plasticity defects, preventing growth cone collapse in chicken retinal explants and dissociated cultures of rat cortical neurons, promoting nerve regeneration and functional recovery in a rat model of spinal cord injury, and inhibiting the adhesion of human T-cells to endothelial cells

References:

https://pubmed.ncbi.nlm.nih.gov/?term=KYL+peptide&sort=date

Analytical data

Price & Availability